AZGP1 and Parkinson disease: Zinc-α-2-glycoprotein(AZGP1), detected in all three biofluids, displayed increased sialylationand core fucosylation in serum but decreased levels in the salivaand urine of PD patients, along with a distinct bifucosylation patternin saliva.